Interim results from a National Institutes of Health (NIH)-supported clinical trial of the Bavarian Nordic mpox vaccine ...

Today, The Lancet published the first real-world data analysis of respiratory syncytial virus (RSV) vaccine efficacy among ...

Time to sustained recovery, defined as 3 or more days without symptoms, didn't differ between the 628 and 622 participants ...

As the country heads into the respiratory illness season, the US Food and Drug Administration (FDA) announced yesterday its marketing authorization of the first over-the-counter (OTC) rapid-antigen ...